OBJECTIVES Assessing long-term success and efficiency is an essential part of evaluating cancer control programs. The mortality-to-incidence ratio (MIR) can serve as an insightful indicator of cancer management outcomes for individual nations. By calculating MIRs for the top five cancers in Organization for Economic Cooperation and Development (OECD) countries, the current study attempted to characterize the outcomes of national cancer management policies according to the health system ranking of each country.
METHODS
The MIRs for the five most burdensome cancers globally (lung, colorectal, prostate, stomach, and breast) were calculated for all 34 OECD countries using 2012 GLOBOCAN incidence and mortality statistics. Health system rankings reported by the World Health Organization in 2000 were updated with relevant information when possible. A linear regression model was created, using MIRs as the dependent variable and health system rankings as the independent variable.
RESULTS
The linear relationships between MIRs and health system rankings for the five cancers were significant, with coefficients of determination ranging from 49 to 75% when outliers were excluded. A clear outlier, Korea reported lower-than-predicted MIRs for stomach and colorectal cancer, reflecting its strong national cancer control policies, especially cancer screening.
CONCLUSIONS
The MIR was found to be a practical measure for evaluating the long-term success of cancer surveillance and the efficacy of cancer control programs, especially cancer screening. Extending the use of MIRs to evaluate other cancers may also prove useful.
Summary
Citations
Citations to this article as recorded by
Global burden of 34 cancers among women in 2020 and projections to 2040: Population‐based data from 185 countries/territories Habtamu Mellie Bizuayehu, Abel F. Dadi, Tahir A. Hassen, Daniel Bekele Ketema, Kedir Y. Ahmed, Zemenu Y. Kassa, Erkihun Amsalu, Getiye Dejenu Kibret, Addisu Alehegn Alemu, Animut Alebel, Jemal E. Shifa, Yibeltal Assefa, Gizachew A. Tessema, Peter Sarich, International Journal of Cancer.2024; 154(8): 1377. CrossRef
Gastric cancer screening in Western countries: A call to action Fabio Farinati, Filippo Pelizzaro Digestive and Liver Disease.2024; 56(10): 1653. CrossRef
Development, acceptability and usability of culturally appropriate survivor narrative videos for breast cancer treatment in Botswana: a pilot study Yehoda M Martei, Lebogang Mokokwe, Ngwao Ngwako, Keaobaka Kebuang, Dipho I Setlhako, Goitsemang Gabaatlhole, Bontswanetse Baaitse, Tumisang Segadimo, Lawrence N Shulman, Frances Barg, Babe E Gaolebale BMJ Open.2024; 14(1): e073867. CrossRef
Disparities in mortality risk after diagnosis of hematological malignancies in 185 countries: A global data analysis Jing Yang, Xin Liu, Qiu-Zi Zhong, Yong Yang, Tao Wu, Si-Ye Chen, Bo Chen, Yong-Wen Song, Hui Fang, Shu-Lian Wang, Yue-Ping Liu, Jing Jin, Ning Li, Ning-Ning Lu, Hao Jing, Yuan Tang, Fan Chen, Xi-Mei Zhang, Wenwen Zhang, Yirui Zhai, Shu-Nan Qi, Ye-Xiong Li Cancer Letters.2024; 595: 216793. CrossRef
Utility of auto fluorescence-guided biopsy in suspected lung cancer patients with bronchial mucosal lesions Gaozhe Wang, Yan Jin, Kunlong Xiong, Xiaoyan Jin, Linfeng Wang, Chenwei Li Photodiagnosis and Photodynamic Therapy.2024; 46: 104057. CrossRef
Policy strategies for capacity building and scale up of the workforce for comprehensive cancer care: a systematic review D. Trapani, S.S. Murthy, N. Hammad, R. Casolino, D.C. Moreira, F. Roitberg, J.-Y. Blay, G. Curigliano, A.M. Ilbawi ESMO Open.2024; 9(4): 102946. CrossRef
Global, regional, and national burdens of early onset pancreatic cancer in adolescents and adults aged 15–49 years from 1990 to 2019 based on the Global Burden of Disease Study 2019: a cross-sectional study Zheng Li, Xiaojie Zhang, Chongyuan Sun, Zefeng Li, He Fei, Dongbing Zhao International Journal of Surgery.2024; 110(4): 1929. CrossRef
Self-Assembly of Peptides as an Alluring Approach toward Cancer Treatment and Imaging Muhammad Hamza Ghafoor, Ben-Li Song, Lei Zhou, Zeng-Ying Qiao, Hao Wang ACS Biomaterials Science & Engineering.2024; 10(5): 2841. CrossRef
Cutaneous Melanoma Mortality-to-Incidence Ratio and Its Association With Socioeconomic and Healthcare Factors in Canada: A National Ecological Study Santina Conte, Michelle Le, Amina Moustaqim-Barrette, Feras M. Ghazawi, Anastasiya Muntyanu, François Lagacé, Akram Alakel, Elham Rahme, Steven J. Glassman, Ivan V. Litvinov Journal of Cutaneous Medicine and Surgery.2024; 28(5): 439. CrossRef
Estimativa de incidência de câncer no Brasil e regiões em 2018: aspectos metodológicos Beatriz Cordeiro Jardim, Washington Leite Junger, Regina Paiva Daumas, Gulnar Azevedo e Silva Cadernos de Saúde Pública.2024;[Epub] CrossRef
Disparities in 36 cancers across 185 countries: secondary analysis of global cancer statistics Qianru Li, Changfa Xia, He Li, Xinxin Yan, Fan Yang, Mengdi Cao, Shaoli Zhang, Yi Teng, Siyi He, Maomao Cao, Wanqing Chen Frontiers of Medicine.2024; 18(5): 911. CrossRef
Burden of 30 cancers among men: Global statistics in 2022 and projections for 2050 using population‐based estimates Habtamu Mellie Bizuayehu, Abel F. Dadi, Kedir Y. Ahmed, Teketo Kassaw Tegegne, Tahir Ahmed Hassen, Getiye Dejenu Kibret, Daniel Bekele Ketema, Meless G. Bore, Subash Thapa, Daniel Bogale Odo, Zemenu Y. Kassa, Desalegn Markos Shifti, Erkihun Amsalu, Peter Cancer.2024;[Epub] CrossRef
Global epidemiology of liver cancer 2022: An emphasis on geographic disparities Qianru Li, Chao Ding, Maomao Cao, Fan Yang, Xinxin Yan, Siyi He, Mengdi Cao, Shaoli Zhang, Yi Teng, Nuopei Tan, Jiachen Wang, Changfa Xia, Wanqing Chen Chinese Medical Journal.2024; 137(19): 2334. CrossRef
Global epidemiology and socioeconomic correlates of hypopharyngeal cancer in 2020 and its projection to 2040: findings from GLOBOCAN 2020 Seyed Ehsan Mousavi, Mehran Ilaghi, Yasaman Mirzazadeh, Alireza Mosavi Jarrahi, Seyed Aria Nejadghaderi Frontiers in Oncology.2024;[Epub] CrossRef
Synthesis of novel propargylated derivatives of noscapine using A3-coupling reaction and their anticancer properties Fatemeh Famarini, Peyman Salehi, Bahareh Heidari, Morteza Bararjanian, Atefeh Hajiagha Bozorgi, Afsaneh Tavasoli, Zahra Davarzani Journal of the Iranian Chemical Society.2024; 21(11): 2841. CrossRef
Cancer profiling in the littoral region of cameroon: Insights from a major health centre Suares Clovis Oukouomi Noutchie International Journal of Research in Business and Social Science (2147- 4478).2024; 13(6): 202. CrossRef
Cell death in glioblastoma and the central nervous system Kyle Malone, Eric LaCasse, Shawn T. Beug Cellular Oncology.2024;[Epub] CrossRef
Global, regional, and national trends of dementia incidence and risk factors, 1990–2019: A Global Burden of Disease study Abolfazl Avan, Vladimir Hachinski Alzheimer's & Dementia.2023; 19(4): 1281. CrossRef
Improved Trends in the Mortality-to-Incidence Ratios for Liver Cancer in Countries with High Development Index and Health Expenditures Chang-Cheng Su, Brian-Shiian Chen, Hsin-Hung Chen, Wen-Wei Sung, Chi-Chih Wang, Ming-Chang Tsai Healthcare.2023; 11(2): 159. CrossRef
Updated epidemiology of gastrointestinal cancers in East Asia Junjie Huang, Don Eliseo Lucero-Prisno, Lin Zhang, Wanghong Xu, Sunny H. Wong, Siew C. Ng, Martin C. S. Wong Nature Reviews Gastroenterology & Hepatology.2023; 20(5): 271. CrossRef
Peptide Self-Assembled Nanocarriers for Cancer Drug Delivery Vijay Bhooshan Kumar, Busra Ozguney, Anastasia Vlachou, Yu Chen, Ehud Gazit, Phanourios Tamamis The Journal of Physical Chemistry B.2023; 127(9): 1857. CrossRef
Stigma and Social Determinants of Health Associated With Fidelity to Guideline-Concordant Therapy in Patients With Breast Cancer Living With and Without HIV in Botswana Yehoda M Martei, Modesty Obasohan, Lebogang Mokokwe, Tlotlo Ralefala, Mosepele Mosepele, Robert Gross, Frances K Barg The Oncologist.2023; 28(12): e1230. CrossRef
Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel Joanne Wing Yan Chiu, Soo Chin Lee, James Chung-man Ho, Yeon Hee Park, Ta-Chung Chao, Sung-Bae Kim, Elgene Lim, Ching-Hung Lin, Sherene Loi, Su Ying Low, Lynette Li San Teo, Winnie Yeo, Rebecca Dent Drug Safety.2023; 46(10): 927. CrossRef
Gender differences in leukemia outcomes based on health care expenditures using estimates from the GLOBOCAN 2020 Maedeh Amini, Rajesh Sharma, Chinmay Jani Archives of Public Health.2023;[Epub] CrossRef
Unfavorable cancer mortality‐to‐incidence ratios in patients with schizophrenia: A nationwide cohort study in Taiwan, 2000–2019 Chu‐Syuan Cheng, Wen‐Yin Chen, Hu‐Ming Chang, Chun‐Hung Pan, Sheng‐Siang Su, Shang‐Ying Tsai, Chiao‐Chicy Chen, Chian‐Jue Kuo Acta Psychiatrica Scandinavica.2023; 148(4): 347. CrossRef
Mortality‐to‐incidence ratio of early‐onset colorectal cancer in high‐income Asian and Middle Eastern countries: A systemic analysis of the Global Burden of Diseases Study 2019 Majed Ramadan, Rawiah A. Alsiary, Doaa A. Aboalola Cancer Medicine.2023; 12(21): 20604. CrossRef
Spiritual coping strategies: Relationship with physical, anxiety, and depression symptoms of patients with cancer Atefeh Ahmadi, Aazam Heidarzadeh, Mahlagha Dehghan, Mohammah Hossein Safarizadeh, Mansooreh Azizzadeh Forouzi Indian Journal of Cancer.2023;[Epub] CrossRef
Assessing the quality of care for skin malignant melanoma on a global, regional, and national scale: a systematic analysis of the global burden of disease study from 1990 to 2019 Mingjuan Liu, Mengyin Wu, Xintong Liu, Jia Zhou, Yining Lan, Hanlin Zhang, Xinyi zhang, Ling Leng, Heyi Zheng, Jun Li Archives of Dermatological Research.2023; 315(10): 2893. CrossRef
The fraction of life years lost after diagnosis (FLYLAD): a person-centred measure of cancer burden David Banham, Jonathan Karnon, Alex Brown, David Roder, John Lynch Population Health Metrics.2023;[Epub] CrossRef
Global trend analysis of diabetes mellitus incidence, mortality, and mortality-to-incidence ratio from 1990 to 2019 Mohammadreza Balooch Hasankhani, Hossein Mirzaei, Ali Karamoozian Scientific Reports.2023;[Epub] CrossRef
Burden of AML, 1990-2019: Estimates From the Global Burden of Disease Study Chinmay T. Jani, Alaaeldin Ahmed, Harpreet Singh, Christian Mouchati, Omar Al Omari, Padmanabh S. Bhatt, Rajesh Sharma, Minaam Farooq, Weitao Liu, Joseph Shalhoub, Dominic Marshall, Justin D. Salciccioli, Jeremy L. Warner, Prudence Lam JCO Global Oncology.2023;[Epub] CrossRef
Type 1 diabetes mellitus disease burden in high health expenditure countries between 1990 and 2019 Michael Edwards, Aurimas Kudzinskas, Andrew Alazawi, Will Hughes, Richard Goodall, Eleanor Harbinson, Justin Salciccioli, Dominic Marshall, Joseph Shalhoub Diabetes and Vascular Disease Research.2023;[Epub] CrossRef
Spatial and temporal patterns of prostate cancer burden and their association with Socio‐Demographic Index in Asia, 1990–2019 Li‐Sha Luo, Jun‐Feng Jiang, Hang‐Hang Luan, Hao Zi, Cong Zhu, Bing‐Hui Li, Xian‐Tao Zeng The Prostate.2022; 82(2): 193. CrossRef
Cancer of unknown primary ‐ incidence, mortality trend, and mortality‐to‐incidence ratio is associated with human development index in Central Serbia, 1999–2018: Evidence from the national cancer registry Aleksandra Ignjatović, Miodrag Stojanović, Zoran Milošević, Marija Anđelković Apostolović, Tamara Filipović, Nataša Rančić, Roberta Marković, Marija Topalović, Dijana Stojanović, Suzana Otašević European Journal of Cancer Care.2022;[Epub] CrossRef
Global, regional, and national burden and quality of care index of endocarditis: the global burden of disease study 1990–2019 Sara Momtazmanesh, Sahar Saeedi Moghaddam, Elaheh Malakan Rad, Sina Azadnajafabad, Narges Ebrahimi, Esmaeil Mohammadi, Mahtab Rouhifard, Negar Rezaei, Masoud Masinaei, Nazila Rezaei, Mohammad Keykhaei, Arya Aminorroaya, Azin Ghamari, Bagher Larijani, Fars European Journal of Preventive Cardiology.2022; 29(8): 1287. CrossRef
Global pattern of trends in incidence, mortality, and mortality-to-incidence ratio rates related to liver cancer, 1990–2019: a longitudinal analysis based on the global burden of disease study Maedeh Amini, Mehdi Azizmohammad Looha, Elaheh Zarean, Mohamad Amin Pourhoseingholi BMC Public Health.2022;[Epub] CrossRef
Mapping Cancer in Africa: A Comprehensive and Comparable Characterization of 34 Cancer Types Using Estimates From GLOBOCAN 2020 Rajesh Sharma, Aashima, Mehak Nanda, Claudio Fronterre, Paul Sewagudde, Anna E. Ssentongo, Kelsey Yenney, Nina D. Arhin, John Oh, Forster Amponsah-Manu, Paddy Ssentongo Frontiers in Public Health.2022;[Epub] CrossRef
Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs Freddie Bray, D Maxwell Parkin, Freddy Gnangnon, Gontse Tshisimogo, Jean-Felix Peko, Innocent Adoubi, Mathewos Assefa, Lamin Bojang, Baffour Awuah, Moussa Koulibaly, Nathan Buziba, Anne Korir, Charles Dzamalala, Bakarou Kamate, Shyam Manraj, Josefo Ferro, The Lancet Oncology.2022; 23(6): 719. CrossRef
Burden of type 1 diabetes mellitus in the North Africa and Middle East Region, 1990–2019; findings from the global burden of disease study Shahnaz Esmaeili, Sahar Saeedi Moghaddam, Nazli Namazi, Fatemeh Bandarian, Zahra Esfahani, Maryam Peimani, Sarvenaz Shahin, Ensieh Nasli-Esfahani, Isa Akbarzadeh, Ali Ghanbari, Negar Rezaei, Nazila Rezaei, Bagher Larijani, Farshad Farzadfar Diabetes Research and Clinical Practice.2022; 188: 109912. CrossRef
Cancer incidence and mortality and risk factors in member countries of the " Belt and Road " initiative Baohua Wang, Fengdie He, Yanan Hu, Qiutong Wang, Dan Wang, Yuting Sha, Jing Wu BMC Cancer.2022;[Epub] CrossRef
Geographical Differences in Kidney Cancer Outcomes of Patients Treated with Immunotherapy: A Systematic Review Vinicius Knackfuss Gonçalves, Fernando Sabino Marques Monteiro, Antonia Angeli Gazola, Felipe Pizzolo, Júlia Elisa Hübner, Rodrigo Pellegrini, Alessandra Borba, André P. Fay Kidney Cancer.2022; 6(2): 129. CrossRef
Global burden of disease study at the world health organization:
research methods for the most comprehensive global study of disease and
underlying health policies Lee Smith, Jae Il Shin, Soo Young Hwang, Kalthoum Tizaoui, Elena Dragioti, Louis Jacob, Karel Kostev, Seung Won Lee, Ai Koyanagi Life Cycle.2022;[Epub] CrossRef
Quality of care of peptic ulcer disease worldwide: A systematic analysis for the global burden of disease study 1990–2019 Mohsen Abbasi-Kangevari, Naser Ahmadi, Nima Fattahi, Negar Rezaei, Mohammad-Reza Malekpour, Seyyed-Hadi Ghamari, Sahar Saeedi Moghaddam, Sina Azadnajafabad, Zahra Esfahani, Ali-Asghar Kolahi, Shahin Roshani, Sahba Rezazadeh-Khadem, Fateme Gorgani, Seyyed PLOS ONE.2022; 17(8): e0271284. CrossRef
A scoping review on population-centered indicators for cancer care continuum Vasuki Rajaguru, Jieun Jang, Jeoung A. Kwon, Jae Hyun Kim, Jaeyong Shin, Mison Chun Frontiers in Public Health.2022;[Epub] CrossRef
COMPARISON OF TEMPORAL TRENDS IN THE GLOBAL BURDEN OF TRACHEA, BRONCHIAL, AND LUNG CANCER İskender ÇETİNTÜRK, Vahit YİĞİT Giresun Üniversitesi İktisadi ve İdari Bilimler Dergisi.2022; 8(2): 254. CrossRef
ANALYSIS OF INCIDENCE AND MORTALITY OF GASTROINTESTINAL MALIGNANT TUMORS IN UKRAINE AND WORLDWIDE Valeriy Zub Acta Medica Leopoliensia.2022; 28(3-4): 22. CrossRef
Global, regional, national burden of breast cancer in 185 countries: evidence from GLOBOCAN 2018 Rajesh Sharma Breast Cancer Research and Treatment.2021; 187(2): 557. CrossRef
A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017 Mohammad Keykhaei, Masood Masinaei, Esmaeil Mohammadi, Sina Azadnajafabad, Negar Rezaei, Sahar Saeedi Moghaddam, Nazila Rezaei, Maryam Nasserinejad, Mohsen Abbasi-Kangevari, Mohammad-Reza Malekpour, Seyyed-Hadi Ghamari, Rosa Haghshenas, Kamyar Koliji, Far Experimental Hematology & Oncology.2021;[Epub] CrossRef
The global landscape of drug development of trastuzumab biosimilars Dario Trapani, Giuseppe Curigliano Journal of Cancer Policy.2021; 28: 100273. CrossRef
Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017 Maedeh Amini, Farid Zayeri, Masoud Salehi BMC Public Health.2021;[Epub] CrossRef
Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: A systematic analysis of the Global Burden of Disease Study 1990–2017 Sina Azadnajafabad, Sahar Saeedi Moghaddam, Esmaeil Mohammadi, Negar Rezaei, Erfan Ghasemi, Nima Fattahi, Arya Aminorroaya, Reza Azadnajafabad, Armin Aryannejad, Nazila Rezaei, Shohreh Naderimagham, Vahid Haghpanah, Ali H. Mokdad, Hossein Gharib, Farshad Cancer Medicine.2021; 10(7): 2496. CrossRef
National and Subnational Incidence, Mortality, and Years of Life Lost Due to Breast Cancer in Iran: Trends and Age-Period-Cohort Analysis Since 1990 Bahar Ataeinia, Sahar Saeedi Moghaddam, Mahsima Shabani, Kimiya Gohari, Ali Sheidaei, Nazila Rezaei, Shohreh Naderimagham, Erfan Ghasemi, Mahtab Rouhifard Khalilabad, Shahin Roshani, Yosef Farzi, Farshad Farzadfar Frontiers in Oncology.2021;[Epub] CrossRef
Honey and its protein components: Effects in the cancer immunology Ivan Chan‐Zapata, Maira Rubí Segura‐Campos Journal of Food Biochemistry.2021;[Epub] CrossRef
A Comparison of the United States and Austrian Healthcare Needs and Systems Margaret McAlister, Joey D. Helton INQUIRY: The Journal of Health Care Organization, Provision, and Financing.2021;[Epub] CrossRef
Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: Comparing between high‐ and middle‐income Asian countries Jasmine Lim, Mizuki Onozawa, Marniza Saad, Teng Aik Ong, Rohan Malek, Hideyuki Akaza Cancer Science.2021; 112(6): 2071. CrossRef
A spatial assessment of prostate cancer mortality-to-incidence ratios among South Carolina veterans: 1999–2015 Peter Georgantopoulos, Jan M. Eberth, Bo Cai, Gowtham Rao, Charles L. Bennett, Christopher T. Emrich, Kathlyn S. Haddock, James R. Hébert Annals of Epidemiology.2021; 59: 24. CrossRef
Assessment of quality benchmarks in adenoma detection in Mexico Nancy E. Aguilar-Olivos, Ricardo Balanzá, Fernando Rojas-Mendoza, Rodrigo Soto-Solis, Mario A. Ballesteros-Amozurrutia, Norma González-Uribe, Justo A. Fernández-Rivero Endoscopy International Open.2021; 09(06): E796. CrossRef
Favorable Lip and Oral Cancer Mortality-to-Incidence Ratios in Countries with High Human Development Index and Expenditures on Health Wen-Wei Sung, Yong-Chen Hsu, Chen Dong, Ying-Ching Chen, Yu-Chi Chao, Chih-Jung Chen International Journal of Environmental Research and Public Health.2021; 18(11): 6012. CrossRef
In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied? Jihae An, Young Joong Kim, Jae Young Seo, Cheol Mog Hwang, Dong Hyun Oh, Mu-Sik Lee, Keum Won Kim Egyptian Journal of Radiology and Nuclear Medicine.2021;[Epub] CrossRef
Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures Tzu-Wei Yang, Chi-Chih Wang, Wei-Cheng Hung, Yu-Hsiang Liu, Wen-Wei Sung, Ming-Chang Tsai Frontiers in Public Health.2021;[Epub] CrossRef
Provider Barriers and Facilitators of Breast Cancer Guideline-Concordant Therapy Delivery in Botswana: A Consolidated Framework for Implementation Research Analysis Tlotlo Ralefala, Lebogang Mokokwe, Swetha Jammalamadugu, Dumelang Legobere, Warona S. Motlhwa, Anthony A. Oyekunle, Surbhi Grover, Frances K. Barg, Lawrence N. Shulman, Yehoda M. Martei The Oncologist.2021; 26(12): e2200. CrossRef
Improving Quality Indicator of Melanoma Management – Change of Melanoma Mortality-to-Incidence Rate Ratio Based on a Hungarian Nationwide Retrospective Study Máté Várnai, Zoltán Kiss, Rolland Gyulai, Judit Oláh, Péter Holló, Gabriella Emri, András Csejtei, István Kenessey, Angéla Benedek, Zoltán Polányi, Zsófia Nagy-Erdei, Andrea Dániel, Kata Knollmajer, György Rokszin, Ibolya Fábián, Zsófia Barcza, Csaba Polg Frontiers in Oncology.2021;[Epub] CrossRef
Cancer survival status among male population of Northeast India Manoj Kalita, Jagannath Dev Sharma, Debanjana Barman, Nizara Baishya, Chandi Ram Kalita Annals of Oncology Research and Therapy.2021; 1(1): 28. CrossRef
Global Burden of Head and Neck Cancer: Economic Consequences, Health, and the Role of Surgery Rolvix H. Patterson, Victoria G. Fischman, Isaac Wasserman, Jennifer Siu, Mark G. Shrime, Johannes J. Fagan, Wayne Koch, Blake C. Alkire Otolaryngology–Head and Neck Surgery.2020; 162(3): 296. CrossRef
Trends of National and Subnational Incidence of Childhood Cancer Groups in Iran: 1990–2016 Mahsima Shabani, Sahar Saeedi Moghaddam, Bahar Ataeinia, Nazila Rezaei, Farnam Mohebi, Bahram Mohajer, Kimiya Gohari, Ali Sheidaei, Farhad Pishgar, Moein Yoosefi, Farzad Kompani, Farshad Farzadfar Frontiers in Oncology.2020;[Epub] CrossRef
Evaluation of the Cardiac Protection Conferred by Proanthocyanidins in Grape Seeds against Development of Ehrlich Solid Tumors in Mice Maha Abdulrahman Aldubayan BioMed Research International.2020; 2020: 1. CrossRef
The economic burden of cancer care for Syrian refugees: a population-based modelling study Rima A Abdul-Khalek, Ping Guo, Forbes Sharp, Adrian Gheorghe, Omar Shamieh, Tezer Kutluk, Fouad Fouad, Adam Coutts, Ajay Aggarwal, Deborah Mukherji, Ghassan Abu-Sittah, Kalipso Chalkidou, Richard Sullivan The Lancet Oncology.2020; 21(5): 637. CrossRef
Multiple Myeloma Incidence and Mortality Around the Globe; Interrelations Between Health Access and Quality, Economic Resources, and Patient Empowerment Heinz Ludwig, Susie Novis Durie, Angela Meckl, Axel Hinke, Brian Durie The Oncologist.2020; 25(9): e1406. CrossRef
Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018 Rajesh Sharma Japanese Journal of Clinical Oncology.2020; 50(12): 1370. CrossRef
Evaluating the Effect of Medicaid Expansion on Black/White Breast Cancer Mortality Disparities: A Difference-in-Difference Analysis Jason Semprini, Olufunmilayo Olopade JCO Global Oncology.2020; (6): 1178. CrossRef
State-Level Disparity in Lung Cancer Survival in the United States Yu-Che Lee, Rafael A. Calderon-Candelario, Gregory E. Holt, Michael A. Campos, Mehdi Mirsaeidi Frontiers in Oncology.2020;[Epub] CrossRef
Inequalities in the burden of female breast cancer in Brazil, 1990–2017 Maximiliano Ribeiro Guerra, Mário Círio Nogueira, Deborah Carvalho Malta, Camila Soares Lima Côrrea, Maria de Fatima Marinho de Souza, Maria Paula Curado, Mariana Santos Felisbino-Mendes, Meghan Mooney, Mohsen Naghavi, Maria Teresa Bustamante-Teixeira Population Health Metrics.2020;[Epub] CrossRef
Disparities in mortality‐to‐incidence ratios by race/ethnicity for female breast cancer in New York City, 2002‐2016 Tamar B. Nobel, Charles K. Asumeng, John Jasek, Kellie C. Van Beck, Ruchi Mathur, Baozhen Qiao, Jennifer J. Brown Cancer Medicine.2020; 9(21): 8226. CrossRef
Enhanced Cancer-targeted Drug Delivery Using Precoated Nanoparticles Lu Yu, Mingyu Xu, Wenwen Xu, Wei Xiao, Xue-hua Jiang, Ling Wang, Huile Gao Nano Letters.2020; 20(12): 8903. CrossRef
Oxaliplatin-Based Intra-arterial Chemotherapy in Colo-Rectal Cancer Liver Metastases: A Review from Pharmacology to Clinical Application Girolamo Ranieri, Mariarita Laforgia, Patrizia Nardulli, Simona Ferraiuolo, Pasquale Molinari, Ilaria Marech, Cosmo Damiano Gadaleta Cancers.2019; 11(2): 141. CrossRef
Melanoma prognosis in the United States: Identifying barriers for improved care Zachary H. Hopkins, Christopher Moreno, Ryan Carlisle, Aaron M. Secrest Journal of the American Academy of Dermatology.2019; 80(5): 1256. CrossRef
The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma Erik Ladomersky, Denise M. Scholtens, Masha Kocherginsky, Elizabeth A. Hibler, Elizabeth T. Bartom, Sebastian Otto-Meyer, Lijie Zhai, Kristen L. Lauing, Jaehyuk Choi, Jeffrey A. Sosman, Jennifer D. Wu, Bin Zhang, Rimas V. Lukas, Derek A. Wainwright Frontiers in Pharmacology.2019;[Epub] CrossRef
The Mortality-to-Incidence Ratio Is Not a Valid Proxy for Cancer Survival Libby Ellis, Aurélien Belot, Bernard Rachet, Michel P. Coleman Journal of Global Oncology.2019; (5): 1. CrossRef
National Cancer Mortality-to-Incidence Ratio (MIR) in Iran (2005 - 2014) Atieh Akbari, Maryam Khayamzadeh, Reza Salmanian, Ali Ghanbari Motlagh, Gholamreza Roshandel, Maryam Nouri, Mohammad Esmaeil Akbari International Journal of Cancer Management.2019;[Epub] CrossRef
The Association between Mortality-to-Incidence Ratios and Health Expenditures in Brain and Nervous System Cancers Tsung-Han Lee, Wen-Wei Sung, Lung Chan, Hsiang-Lin Lee, Sung-Lang Chen, Yu-Hui Huang, Aij-Lie Kwan International Journal of Environmental Research and Public Health.2019; 16(15): 2739. CrossRef
miR‐181a/b therapy in lung cancer: reality or myth? Cornelia Braicu, Diana Gulei, Roxana Cojocneanu, Lajos Raduly, Ancuta Jurj, Erik Knutsen, George Adrian Calin, Ioana Berindan‐Neagoe Molecular Oncology.2019; 13(1): 9. CrossRef
Breast Cancer: Reimbursement Policies and Adoption of New Therapeutic Agents by National Health Systems Dario Trapani, Giuseppe Curigliano, Alexandru Eniu Breast Care.2019; 14(6): 373. CrossRef
Epidemiology of prostate cancer in Asian countries Takahiro Kimura, Shin Egawa International Journal of Urology.2018; 25(6): 524. CrossRef
Cause-of-death statistics in 2016 in the Republic of Korea Hyun-Young Shin, Ji-Youn Lee, Jee-Eun Kim, Seokmin Lee, Heejo Youn, Heyran Kim, Jeonghun Lee, Min Sim Park, Sun Huh Journal of the Korean Medical Association.2018; 61(9): 573. CrossRef
Is mortality-to-incidence ratio associated with health disparity in pancreatic cancer? A cross-sectional database analysis of 57 countries Hsiang-Lin Lee, Cheng-Ming Peng, Cheng-Yu Huang, Shin-Yi Wu, Ming-Chang Tsai, Chi-Chih Wang, Sung-Lang Chen, Chun-Che Lin, Chien-Ning Huang, Wen-Wei Sung BMJ Open.2018; 8(7): e020618. CrossRef